These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 17408026

  • 1. [The role of dendritic cells in the infection by HIV and HCV].
    Belmonte L, Parodi C, Bare P, Baston M, Bracco MM, Ruibal-Ares B.
    Medicina (B Aires); 2007; 67(1):63-70. PubMed ID: 17408026
    [Abstract] [Full Text] [Related]

  • 2. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
    Gonzalez VD, Landay AL, Sandberg JK.
    Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M, Khushboo I, Singh S, Singh S.
    Int Rev Immunol; 2008 Apr; 27(6):497-517. PubMed ID: 19065353
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
    Bode JG, Brenndörfer ED, Häussinger D.
    Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunopathogenesis in hepatitis C virus cirrhosis.
    Spengler U, Nattermann J.
    Clin Sci (Lond); 2007 Feb; 112(3):141-55. PubMed ID: 17199558
    [Abstract] [Full Text] [Related]

  • 12. Modulation of dendritic cell function by persistent viruses.
    Liu B, Woltman AM, Janssen HL, Boonstra A.
    J Leukoc Biol; 2009 Feb; 85(2):205-14. PubMed ID: 18818373
    [Abstract] [Full Text] [Related]

  • 13. GB virus type C-driven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation.
    Martini F, Sacchi A, Lalle E, Castilletti C, D'Offizi G, Abbate I, Capobianchi MR.
    Gastroenterology; 2008 May; 134(5):1631-3; author reply 1633. PubMed ID: 18471541
    [No Abstract] [Full Text] [Related]

  • 14. The molecular basis of HCV-mediated immune dysregulation.
    Eisen-Vandervelde AL, Yao ZQ, Hahn YS.
    Clin Immunol; 2004 Apr; 111(1):16-21. PubMed ID: 15093547
    [Abstract] [Full Text] [Related]

  • 15. Presentation of HCV antigens to naive CD8+T cells: why the where, when, what and how are important for virus control and infection outcome.
    Racanelli V, Manigold T.
    Clin Immunol; 2007 Jul; 124(1):5-12. PubMed ID: 17540619
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fundamental mechanisms of host immune responses to infection.
    Azuma M.
    J Periodontal Res; 2006 Oct; 41(5):361-73. PubMed ID: 16953812
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.